5 Pharmaceutical Stocks to Buy According to Lawrence Hawkins’ Prosight Capital

3. Haemonetics Corporation (NYSE:HAE)

Prosight Capital Stake Value: $8.9 million

Percentage of Prosight Capital’s 13F Portfolio: 5.58%

No. of Hedge Fund Holders: 30

Haemonetics Corporation (NYSE:HAE), headquartered in Boston, Massachusetts, is ranked third on the list of 10 pharmaceutical stocks to buy according to Lawrence Hawkins’ Prosight Capital. The company creates, manufactures and sells automated blood processing equipment.

Hawkins’ Prosight Capital owns 134,000 shares worth $8.9 million in Haemonetics Corporation (NYSE:HAE) which represents 5.58% of Hawkins’ 13F portfolio.

At the end of the second quarter of 2021, 30 hedge funds in the database of Insider Monkey held stakes worth $392.9 million in Haemonetics Corporation (NYSE:HAE), down from 37 the preceding quarter worth $585.5 million.